2 results
A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder
-
- Journal:
- Acta Neuropsychiatrica / Volume 31 / Issue 1 / February 2019
- Published online by Cambridge University Press:
- 18 September 2018, pp. 27-35
-
- Article
- Export citation
Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
-
- Journal:
- Acta Neuropsychiatrica / Volume 29 / Issue 5 / October 2017
- Published online by Cambridge University Press:
- 16 November 2016, pp. 278-290
-
- Article
- Export citation